V
Vinod Pullarkat
Researcher at City of Hope National Medical Center
Publications - 280
Citations - 9132
Vinod Pullarkat is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 37, co-authored 219 publications receiving 6536 citations. Previous affiliations of Vinod Pullarkat include University of Southern California & Biogen Idec.
Papers
More filters
Journal ArticleDOI
The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.
Ryotaro Nakamura,Roberto Rodriguez,Auayporn Nademanee,Joycelynne Palmer,David Senitzer,David S. Snyder,Jasmine Zain,Vinod Pullarkat,Stephen J. Forman,Pablo M. Parker +9 more
TL;DR: The result show the combination of sirolimus, tacrolimus and low-dose methotrexate is shown to be effective in preventing GVHD after unrelated donor hematopoietic stem cell transplantation.
Journal ArticleDOI
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens.
Janny M. Yao,Dongyun Yang,Mary C. Clark,Salman Otoukesh,Thai Cao,Haris Ali,Shukaib Arslan,Ibrahim Aldoss,Andrew S. Artz,I. Amanam,Amandeep Salhotra,Vinod Pullarkat,Karamjeet S. Sandhu,Anthony S. Stein,Guido Marcucci,Stephen J. Forman,Ryotaro Nakamura,Monzr M. Al Malki +17 more
TL;DR: In this paper, a consecutive case series of 210 patients who received PTCy/TAC-based prophylaxis post-hematopoietic cell transplantation from 1/2013-6/2018 was retrospectively analyzed.
Journal ArticleDOI
Proteomics Profiling of Leukemia Derived Exosomes: A Potential Role in Leukemic Transformation
Bijender Kumar,Lei Zhang,Yunan Miao,Gerald E. Wuenschell,Allen Lin,Vinod Pullarkat,Guido Marcucci,Robert J. Hickey,Ching-Cheng Chen +8 more
TL;DR: It is hypothesize that identifying proteins that are differentially expressed on the exosomes among normal and leukemic cells will provide signature biomarkers and offer insight into the mechanism(s) contributing to the transformation of the leukedmic niche.
Journal ArticleDOI
Frequency and Characteristics of Pegaspargase Antibodies in Adults Treated with a Pediatric Acute Lymphoblastic Leukemia Regimen
TL;DR: The frequency and characteristics of PEG-ASN Abs in adults treated by a pediatric ALL regimen are reported, which are similar between Ab formers and the 16 non-formers regarding age, sex, presenting WBC count, immunophenotype, Philadelphia chromosome, and disease risk.
Journal ArticleDOI
Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.
Ryotaro Nakamura,Joycelynne Palmer,Pablo Parker,Anthony S. Stein,Tracey Stiller,Vinod Pullarkat,David S. Snyder,Ji-Lian Cai,Shirong Wang,David Senitzer,Karen L. Chang,Ravi Bhatia,Stephen J. Forman,Margaret R. O'Donnell +13 more
TL;DR: The combined, updated results from a consecutive case-series of 89 patients with MDS (including AML progressed from MDS) who underwent RI-HCT from 2000 to 2008 and received either CSA/MMF or FK/SIRO-based GVHD prophylaxis are reported.